-
GENERAL-PURPOSE VERSUS DOMAIN-SPECIFIC AI FOR SYSTEMATIC CONFOUNDER IDENTIFICATION IN MULTIPLE SCLEROSIS: A COMPARATIVE METHODOLOGICAL STUDY USING IQWIG ASSESSMENTS AS GROUND TRUTH
Mar 18, 2026, 21:38 PM -
HEALTHCARE COST ASSOCIATED WITH CARDIOVASCULAR-KIDNEY-METABOLIC (CKM) SYNDROME STAGES AMONG ADULTS IN THE UNITED STATES: ANALYSIS OF NATIONALLY REPRESENTATIVE DATA
Mar 18, 2026, 21:38 PM -
REGULATORY CHALLENGES AND INSIGHTS FROM FDA IN 2025; POTENTIAL IMPLICATIONS OF THE PLAUSIBLE MECHANISM PATHWAY AND SUBSEQUENT HEALTH TECHNOLOGY ASSESSMENTS
Mar 18, 2026, 21:38 PM -
BUDGET IMPACT ANALYSIS OF PATIENTS WITH NAMD OR DME WHO MAY REQUIRE MONTHLY DOSING WITH AFLIBERCEPT 8 MG
Mar 18, 2026, 21:38 PM -
ONE GLOBAL EVIDENCE PLAN FOR MANY DECISION-MAKERS: ALIGNING EVIDENCE FOR EU JCA, AMCP DOSSIER, AND ICER REVIEWS
Mar 18, 2026, 21:38 PM -
REAL-WORLD TREATMENT PATTERNS AND HOSPITALIZATION FREQUENCY OF ASTHMA IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
DECISION MODEL EVALUATING CLINICAL EVENT-RELATED COSTS OF PERSISTING WITH APIXABAN COMPARED WITH SWITCHING TO RIVAROXABAN AFTER A BLEEDING EVENT IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
COST OF 5-YEAR PROGRESSION FREE SURVIVAL ANALYSIS OF TRIPLE-CLASS EXPOSED PATIENTS WITH REFRACTORY/RELAPSED MULTIPLE MYELOMA TREATED WITH CILTACABTAGENE AUTOLEUCEL IN THE BRAZILIAN PRIVATE HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
ENHANCING TRANSFUSION MEDICINE EFFICIENCY THROUGH NAT SYSTEM TECHNOLOGY INNOVATION
Mar 18, 2026, 21:38 PM -
AI AGENT FOR AUTOMATED QUALITY CHECK OF MS EXCEL BASED COST-EFFECTIVENESS MODELS
Mar 18, 2026, 21:38 PM -
EMERGING PATTERNS OF GLP-1 MICRODOSING IN A LARGE REAL-WORLD POPULATION
Mar 18, 2026, 21:38 PM -
COMPARISON OF AI-ASSISTED AND TRADITIONAL ANALYTIC WORKFLOWS IN HEALTH ECONOMICS AND OUTCOMES RESEARCH USING HEALTH SURVEY DATA
Mar 18, 2026, 21:38 PM -
DYNAMIC POPULATION MODELING FOR TOBACCO HARM REDUCTION - A TIME-SERIES APPROACH
Mar 18, 2026, 21:38 PM -
EXPLORING PREFERENCES FOR LYME DISEASE VACCINES IN THE UNITED STATES: A LATENT CLASS APPROACH
Mar 18, 2026, 21:38 PM -
ASSOCIATION BETWEEN INTRA- AND POST-OPERATIVE SURGICAL COMPLICATIONS AND HEALTH ECONOMIC OUTCOMES IN PATIENTS UNDERGOING ROUX-EN-Y GASTRIC BYPASS: A RETROSPECTIVE DATABASE ANALYSIS
Mar 18, 2026, 21:38 PM -
REAL-WORLD PERIOPERATIVE IMMUNOTHERAPY AND CELLULAR THERAPY IN OLDER ADULTS WITH SOLID TUMORS: A 2021-2025 MEDICARE-EMR LINKED ANALYSIS
Mar 18, 2026, 21:38 PM -
ECONOMIC BURDEN AND COST EFFECTIVENESS OF ADVANCED GALLBLADDER CANCER TREATMENT IN NORTHEAST INDIA: A DUAL PHASE ASSESSMENT
Mar 18, 2026, 21:38 PM -
EXPLORING THE RELATIONSHIP BETWEEN HEALTH-RELATED SOCIAL NEEDS AND CHRONIC DISEASE AMONG JEFFERSON HEALTH PATIENTS
Mar 18, 2026, 21:38 PM -
PHARMACOECONOMIC EVALUATION OF DIFFERENT GONADOTROPIN-RELEASING HORMONE ANALOGS IN THE TREATMENT OF PREMENOPAUSAL HORMONE RECEPTOR-POSITIVE BREAST CANCER IN CHINA
Mar 18, 2026, 21:38 PM -
APPLICATION OF THE ELEVATE-GENAI FRAMEWORK TO AN AI AGENTIC SYSTEM FOR DATA ANALYTICS
Mar 18, 2026, 21:38 PM
